NATIONAL GRAPHITE CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.068 USD | +54.55% |
|
0.00% | +30.77% |
| 2015 | Wolfgang Kochs to Resign from National Graphite Corp. as Director and Chief Financial Officer | CI |
| 2015 | National Graphite Corp. cancelled the transaction announced on October 17, 2012 | CI |
Financials (USD)
| Sales 2014 | - | Sales 2015 | - | Capitalization | 7.61M |
|---|---|---|---|---|---|
| Net income 2014 | - | Net income 2015 | -1M | EV / Sales 2014 | - |
| Net Debt 2014 | 23.32K | Net Debt 2015 | 2.1M | EV / Sales 2015 | - |
| P/E ratio 2014 |
-1.48
x | P/E ratio 2015 |
-3.21
x | Employees | 1 |
| Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 63.71% |
More Fundamentals
* Assessed data
More news
| 1 day | +54.55% | ||
| Current month | -14.89% | ||
| 1 month | +11.48% | ||
| 3 months | +43.16% | ||
| 6 months | +37.37% | ||
| Current year | +30.77% |
1 month
0.04
0.12
Current year
0.040.12
1 year
0.040.12
3 years
0.010.25
5 years
0.000.45
10 years
0.000.73
| Managers | Title | Age | Since |
|---|---|---|---|
John Chui
CEO | Chief Executive Officer | - | - |
Joe Wan
DFI | Director of Finance/CFO | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
John Chui
CEO | Chief Executive Officer | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | - | +-NaN% | 19 |
| 24-04-16 | - | -100.00% | 5 |
Delayed Quote OTC Markets, April 15, 2024 at 12:08 pm EDT
More quotes
National Graphite Corp., formerly Lucky Boy Silver Corporation, is a biopharmaceutical risk/cost-sharing company. The Company is pursuing the commercial development of a drug candidate, elafin, for the treatment of postoperative inflammatory complications. Elafin is a human identic protein. The Company operates in Germany, in collaboration with clinical-stage companies that develop new biological entities or new therapeutically platforms in the treatment for various diseases, rare diseases and diseases with unmet needs. Biotech Development Corp. is the Company's subsidiary. As of February 28, 2015, the Company had not generated any revenues.
| 1st Jan change | Capi. | |
|---|---|---|
| +30.77% | 10.49M | |
| -2.26% | 103B | |
| +1.41% | 95.71B | |
| +0.93% | 22.02B | |
| -17.84% | 20.9B | |
| -11.11% | 17.85B | |
| -42.83% | 16.21B | |
| -17.63% | 15.52B | |
| +4.55% | 13.86B | |
| +32.11% | 12.04B |
- Stock Market
- Equities
- NGRC Stock
